Effects of Foot Bath Therapy on Premenstrual Syndrome Symptoms, Quality of Life, and Pain
The Effects of Footbath on Premenstrual Syndrome Symptoms, Quality of Life, and Pain: A Randomized Controlled Clinical Trial
1 other identifier
interventional
92
1 country
1
Brief Summary
The study was conducted as a randomized controlled trial to evaluate the effects of foot bath application on symptom severity, quality of life, and pain levels in women with premenstrual syndrome. The research was carried out with 92 midwifery students. While foot bath therapy was applied to the experimental group, no intervention was performed in the control group. Data were collected through face-to-face interviews using the Personal Information Form, Premenstrual Symptom Scale, Visual Analog Scale, and SF-36 Quality of Life Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 13, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedApril 22, 2026
March 1, 2026
8 months
February 13, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Personal Information Form
The Personal Information Form was developed by the researchers to determine the participants' sociodemographic and menstrual characteristics.
Pretest assessments were administered to all participants in both groups before the intervention.
Premenstrual Syndrome Scale (PMSS)
The Premenstrual Syndrome Scale (PMSS) was developed by Gençdoğan (2006) based on DSM-III and DSM-IV-TR diagnostic criteria to assess the severity of premenstrual symptoms. The scale consists of 44 items and is structured as a 5-point Likert-type instrument. Each item is rated between "Never" (1 point) and "Always" (5 points), and higher total scores indicate greater symptom severity. The scale includes nine subdimensions: depressive mood, anxiety, fatigue, irritability, depressive thoughts, pain, appetite changes, sleep changes, and bloating.
* "Baseline 1" * "3 months later" * "4 weeks later" * "approximately 4months"
Visual Analog Scale (VAS)
The Visual Analog Scale (VAS) is a one-dimensional measurement tool used to assess pain intensity and was first developed by Hayes and Patterson (1921). The scale consists of a 10-cm (100 mm) horizontal or vertical line anchored by "No pain" at one end and "Unbearable pain" at the other. Participants are asked to mark the point that best represents their perceived pain intensity. The VAS is widely accepted as a reliable and sensitive tool for measuring pain severity in clinical research (Ahearn, 1997).
* "Baseline 1" * "3 months later" * "4 weeks later" * "Approximately 4months"
SF-36 Short Form
The SF-36 is a 36-item self-report instrument developed to evaluate health-related quality of life. The scale measures eight domains: physical functioning, role limitations due to physical problems, bodily pain, general health perception, energy/fatigue, social functioning, role limitations due to emotional problems, and mental well-being. Scores are calculated according to standardized scoring procedures, with higher scores indicating better quality of life. The Turkish validity and reliability of the scale were established by Demiral et al. (2006).
* "Baseline 1" * "3 months later" * "4 weeks later" * "Approximately 4months"
Study Arms (2)
Experimental: Group 1 Foot bath therapy
EXPERIMENTALFoot bath therapy
Group 2
NO INTERVENTIONInterventions
Foot bath therapy was applied during the luteal phase of three menstrual cycles.
Eligibility Criteria
You may qualify if:
- and 25 years of age
- Having no chronic disease
- Having a symptom severity score of 5 or higher according to the VAS,
- Voluntarily agreeing to participate in the study.
You may not qualify if:
- Psychiatric disorder
- Secondary dysmenorrhea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İnonü Universty
Ağrı, Ağrı, 04100, Turkey (Türkiye)
Related Publications (3)
Demiral, Y., Ergor, G., Unal, B., Semin, S., Akvardar, Y., Kivircik, B., & Alper, Z. (2006). Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health, 6, 247. https://doi.org/10.1186/1471-2458-6-247
RESULTAhearn, E. P. (1997). The use of visual analog scales in mood disorders: A critical review. Journal of Psychiatric Research, 31(5), 569-579.
RESULTGençdoğan, B. (2006). Development of a scale for measuring premenstrual syndrome symptoms. Turkish Psychological Counseling and Guidance Journal, 3(26), 51-58.
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant Professor
Study Record Dates
First Submitted
February 13, 2026
First Posted
March 10, 2026
Study Start
August 1, 2024
Primary Completion
April 1, 2025
Study Completion
June 1, 2025
Last Updated
April 22, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
we don't share individual participant data with other researchers